|
Back to Home » March 2021 News » BioArctic and Eisai presented latest data regarding lecanemab at AD/PD 2021 |
BioArctic and Eisai presented latest data regarding lecanemab at AD/PD 2021 |
March 15, 2021
STOCKHOLM, March 15, 2021 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced data on the drug candidate lecanemab (BAN2401), which were presented by the company and its partner Eisai at the 15th International Conference on Alzheimer's and Parkinson's Diseases...
Source URL: https://www.prnewswire.com:443/news-releases/bioarctic-and-eisai-presented-latest-data-regarding-lecanemab-at-adpd-2021-301247102.html
|
|
|
|
